Rare diseases
Investigational molecules
Locations
331 conditions with trials, the busiest first
872 trials across Europe, recruiting first
Study on Anifrolumab for Adults with Polymyositis or Dermatomyositis
AustriaStudy on Long-Term Safety of Ianalumab for Patients with Systemic Lupus Erythematosus
BulgariaStudy on the Effectiveness and Safety of Deucravacitinib for Adults with Active Sjogren's Syndrome
AustriaPhase III trial evaluating ianalumab with background drug combination in patients with Sjögren's disease
AustriaA double‑blind, placebo‑controlled trial of oral BI 1015550 in patients with systemic sclerosis
AustriaSafety Study of CD19.CAR T Cells in Patients with Autoimmune‑Associated Severe Interstitial Lung Fibrosis
GermanySafety and Efficacy of BMS-986528 with Tocilizumab in Patients with Refractory Rheumatoid Arthritis: A Phase 1/2a Open‑Label Study
GermanyA Phase 2a Study of Empasiprubart IV Monotherapy in Adults with AChR‑Ab Seropositive Generalized Myasthenia Gravis
BelgiumCabozantinib Maintenance Therapy vs Best Supportive Care in Osteosarcoma Patients in Complete Remission or with Residual Disease after First‑Line Chemotherapy
DenmarkA Phase 3 Study of Enpatoran to Treat Active Cutaneous Lupus in Patients With or Without Systemic Disease
BelgiumPhase 3 Study of Enpatoran in Patients with Active Cutaneous Lupus Erythematosus (with or without Systemic Disease)
BelgiumWeekly Somatrogon versus Daily Somatropin in Children with Small for Gestational Age or Idiopathic Short Stature
CzechiaThe therapies tested most often in Musculoskeletal and connective tissue disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
